Oramed Pharma (ORMP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 64,016 | -19,103 | 5,088 | -37,764 | -12,255 |
| Depreciation Amortization | 121 | 193 | 196 | 58 | 18 |
| Income taxes - deferred | 7,911 | N/A | N/A | N/A | N/A |
| Other Working Capital | -1,802 | 3,200 | -2,696 | -943 | -699 |
| Other Operating Activity | -79,391 | 7,298 | -12,883 | 10,731 | 1,814 |
| Operating Cash Flow | $-9,145 | $-8,412 | $-10,295 | $-27,918 | $-11,122 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 36,521 | 42,702 | 18,391 | 26,500 | -100,000 |
| PPE Investments | -9 | -18 | -254 | -472 | -9 |
| Purchase Of Investment | -73,886 | -1,307 | -99,550 | -2,705 | N/A |
| Sale Of Investment | 45,817 | 64,500 | 5,000 | N/A | N/A |
| Other Investing Activity | -3,000 | -60 | 3,375 | 6,888 | 761 |
| Investing Cash Flow | $5,443 | $105,817 | $-73,038 | $30,211 | $-99,248 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | 99,550 | N/A | N/A |
| Debt Repayment | N/A | -49,550 | -50,000 | N/A | N/A |
| Common Stock Issued | N/A | N/A | 2,428 | 11,562 | 60,572 |
| Common Stock Repurchased | -4,741 | -2,484 | N/A | N/A | N/A |
| Other Financing Activity | 0 | -2 | 0 | -783 | 0 |
| Financing Cash Flow | $-4,741 | $-52,036 | $51,978 | $10,779 | $60,572 |
| Exchange Rate Effect | -30 | -4 | -54 | -64 | 9 |
| Beginning Cash Position | 54,420 | 9,055 | 40,464 | 27,456 | 77,245 |
| End Cash Position | 45,947 | 54,420 | 9,055 | 40,464 | 27,456 |
| Net Cash Flow | $-8,473 | $45,365 | $-31,409 | $13,008 | $-49,789 |
| Free Cash Flow | |||||
| Operating Cash Flow | -9,145 | -8,412 | -10,295 | -27,918 | -11,122 |
| Capital Expenditure | -9 | -18 | -254 | -496 | -9 |
| Free Cash Flow | -9,154 | -8,430 | -10,549 | -28,414 | -11,131 |